Kazuhiro Yoshida

Synthesis and application of novel chiral phosphino-oxazoline ligands with 1,1′-binaphthyl skeleton

Abstract C 1 -Symmetric phosphino-oxazolines, ( S,S )- and ( S,R )-2-[4-(isopropyl)oxazol-2-yl]-2′-diphenylphosphino-1,1′-binaphthyl, which possess both phosphine and oxazoline moieties, were prepared from racemic binaphthol and enantiomerically pure ( S )-(+)-2-amino-3-methyl-1-butanol in high yields. Reaction of 1,3-diphenyl-2-propenyl acetate with dimethyl sodiomalonate in the presence of 2 mol% of palladium catalysts bearing the new chiral ligands proceeded with high enantioselectivity to give allylic alkylation products of up to 91% ee.

Nardilysin Enhances Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor through Activation of Tumor Necrosis Factor-α-converting Enzyme

Like other members of the epidermal growth factor family, heparin-binding epidermal growth factor-like growth factor (HB-EGF) is synthesized as a transmembrane protein that can be shed enzymatically to release a soluble growth factor. Ectodomain shedding is essential to the biological functions of HB-EGF and is strictly regulated. However, the mechanism that induces the shedding remains unclear. We have recently identified nardilysin (N-arginine dibasic convertase (NRDc)), a metalloendopeptidase of the M16 family, as a protein that specifically binds HB-EGF (Nishi, E., Prat, A., Hospital, V., Elenius, K., and Klagsbrun, M. (2001) EMBO J. 20, 3342-3350). Here, we show that NRDc enhances ectodomain shedding of HB-EGF. When expressed in cells, NRDc enhanced the shedding in cooperation with tumor necrosis factor-α-converting enzyme (TACE; ADAM17). NRDc formed a complex with TACE, a process promoted by phorbol esters, general activators of ectodomain shedding. NRDc enhanced TACE-induced HB-EGF cleavage in a peptide cleavage assay, indicating that the interaction with NRDc potentiates the catalytic activity of TACE. The metalloendopeptidase activity of NRDc was not required for the enhancement of HB-EGF shedding. Notably, a reduction in the expression of NRDc caused by RNA interference was accompanied by a decrease in ectodomain shedding of HB-EGF. These results indicate the essential role of NRDc in HB-EGF ectodomain shedding and reveal how the shedding is regulated by the modulation of sheddase activity.

Enhancement of α‐secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin

Amyloid‐β (Aβ) peptide, the principal component of senile plaques in the brains of patients with Alzheimer’s disease, is derived from proteolytic cleavage of amyloid precursor protein (APP) by β‐ and γ‐secretases. Alternative cleavage of APP by α‐secretase occurs within the Aβ domain and precludes generation of Aβ peptide. Three members of the ADAM (a disintegrin and metalloprotease) family of proteases, ADAM9, 10 and 17, are the main candidates for α‐secretases. However, the mechanism that regulates α‐secretase activity remains unclear. We have recently demonstrated that nardilysin (EC 3.4.24.61, N‐arginine dibasic convertase; NRDc) enhances ectodomain shedding of heparin‐binding epidermal growth factor‐like growth factor through activation of ADAM17. In this study, we show that NRDc enhances the α‐secretase activity of ADAMs, which results in a decrease in the amount of Aβ generated. When expressed with ADAMs in cells, NRDc dramatically increased the secretion of α‐secretase‐cleaved soluble APP and reduced the amount of Aβ peptide generated. A peptide cleavage assay in vitro also showed that recombinant NRDc enhances ADAM17‐induced cleavage of the peptide substrate corresponding to the α‐secretase cleavage site of APP. A reduction of endogenous NRDc by RNA interference was accompanied by a decrease in the cleavage by α‐secretase of APP and increase in the amount of Aβ generated. Notably, NRDc is clearly expressed in cortical neurons in human brain. Our results indicate that NRDc is involved in the metabolism of APP through regulation of the α‐secretase activity of ADAMs, which may be a novel target for the treatment of Alzheimer’s disease.

Ectodomain shedding of TNF-α is enhanced by nardilysin via activation of ADAM proteases

Tumor necrosis factor-alpha (TNF-alpha) is released from cells by proteolytic cleavage of a membrane-anchored precursor. The TNF-alpha-converting enzyme (TACE/ADAM17) is the major sheddase for ectodomain shedding of TNF-alpha. At present, however, it is poorly understood how its catalytic activity is regulated. Here, we show that nardilysin (N-arginine dibasic convertase; NRDc) enhanced TNF-alpha shedding. In a cell-based shedding assay, expression of NRDc synergistically enhanced TACE-induced TNF-alpha shedding. A peptide cleavage assay in vitro showed that recombinant NRDc enhances the cleavage of TNF-alpha induced by TACE. Notably, co-incubation of NRDc completely reversed the inhibitory effect of a physiological concentration of salt on TACEs activity in vitro. Overexpression of NRDc in TACE-deficient fibroblasts resulted in an increase in the amount of TNF-alpha released. Co-expression of NRDc with ADAM10 promoted the release compared with the sole expression of ADAM10. These results suggested that NRDc enhances TNF-alpha shedding through activation of not only TACE but ADAM10. Our results indicate the involvement of NRDc in ectodomain shedding of TNF-alpha, which may be a novel target for anti-inflammatory therapies.